Study probes why blood thinner fails in seniors
NCT ID NCT04990596
First seen Apr 01, 2026 · Last updated May 25, 2026 · Updated 10 times
Summary
This study looked at why older adults (over 70) often don't respond well to clopidogrel, a drug that prevents blood clots. Researchers measured drug levels and platelet activity in 37 patients aged 50-100. The goal was to understand how age affects the body's processing of the drug, which could lead to better treatment for older patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de RENNES
Rennes, France
-
Hôpital Charles Foix
Paris, France
-
Hôpital Européen Georges Pompidou,
Paris, France
-
Hôpital Lariboisière
Paris, France
Conditions
Explore the condition pages connected to this study.